Warning: mysql_num_rows() expects parameter 1 to be resource, boolean given in /home/gurufocu/public_html/include/common_stock_functions_2.php on line 3308

Last Update: 12-31-1969

Number of Stocks:
Number of New Stocks:

Total Value: $0 Mil
Q/Q Turnover: %

Countries: USA
Details: Top Buys | Top Sales | Top Holdings  Embed:

Watch

  • Weekly CFO Sells Highlight

    According to GuruFocus Insider Data, the recent CFO sells were: Lowe's Companies Inc. (NYSE:LOW), Facebook Inc. (NASDAQ:FB), and Salesforce.com Inc. (NYSE:CRM).

      


  • Weekly CFO Buys Highlight

    According to GuruFocus Insider Data, the recent CFO buys were: J. Alexander's Holdings Inc. (NYSE:JAX), Good Times Restaurants Inc. (NASDAQ:GTIM), and Empire Resources Inc. (NASDAQ:ERS).

      


  • 5 Companies Have Hit Their 52 Week Highs

    According to GuruFocus list of 52-week highs, these Guru stocks have reached their 52-Week Highs.



    Waste Management Inc (WM) Reached the 52-Week High of $61.33

      


  • Charles Brandes sells out stake in OmniVision Technologies Inc

    Guru Charles Brandes (Trades, Portfolio) sells out stake in Omnivision Technologies.


    Below is a chart that shows Charles Brandes (Trades, Portfolio) trades for OmniVision Technology Inc

      


  • Many of Ron Baron's 1st-Quarter Divestitures Are Overvalued Today

    Ron Baron (Trades, Portfolio) of Baron Funds sold more than 40 stakes in the first quarter. Many of his largest divestitures are overvalued today, according to the DCF Calculator.


    Baron’s most noteworthy sale of the first quarter was the divestiture of his 12,971,289-share stake in ITC Holdings Corp. (NYSE:ITC), the Novi, Michigan-based parent company of ITC Transmission, for an average price of $40.55 per share. The deal had a -2.36% impact on Baron’s portfolio.

      


  • Scoop Up First Solar On The Irrational Pullback

    When it comes to profitability in the solar sector, First Solar (NASDAQ:FSLR) has the best track record. However, that track record did not stop shares of First Solar from tanking when the company reported its latest quarterly results.


    In the latest reported quarter, First Solar shared EPS of $1.66, thumping the analysts’ estimates by $0.73. On the revenue front, First Solar’s reported roughly 81% sales growth on a year over year basis to $848 million, falling short of the analysts’ estimate by $118 million. First Solar also adjusted its EPS guidance and now expects 2016 EPS of $4.10-$4.50 as compared to the prior guidance of $4.00-$4.50. The consensus of $4.30 falls exactly in the middle of the guidance range.

      


  • Should You Follow Warren Buffett And Buy Apple?

    Warren Buffett (Trades, Portfolio)’s Berkshire Hathaway bought a billion dollar stake in Apple (NASDAQ:AAPL) after the stock tanked in response to the post-earnings debacle. Since Buffett’s stake was disclosed, Apple has jumped almost 10% and has moved over $100.

    The recovery in Apple’s stock has been terrific considering that it moved below $90 for a small amount of time. That being said, I don’t think investors should follow Buffett just yet as Apple may pullback more and here’s why.  


  • Wide margin of safety for these stocks

    The following stocks are trading with wide margins of safety, according to the DCF calculator, and some of them have very low P/E ratios. GuruFocus' All-in-One Screener can be used to find similar stocks.


    Universal Insurance Holdings Inc. (UVE) has a market cap of $688.61 million and a GuruFocus’ business predictability of 3.5/5 stars. The stock has a price of $19.39 with a P/E ratio of 6.40 and according to the DCF calculator is trading with a margin of safety of 77%, since its fair value is $83.45. During the last 12 months the price of the stock has dropped by 24% and is now 48.01% below its 52-week high.

      


  • Choose Your Weapon - John Hussman

    Prevailing market conditions continue to hold the expected stock market return/risk profile in the most negative classification we identify. That profile reflects not only extreme valuations on the most reliable measures we’ve tested across history, but market internals and other features of market action that remain unfavorable. A sufficient improvement in market internals here would shift the expected market return/risk profile to a more neutral classification. That, coupled with a broader improvement in economic factors, mirroring conditions that prevailed during much of this half-cycle prior to mid-2014, could support an outlook - even at presently obscene valuations - that we might characterize as “constructive with a safety-net.” So while our immediate outlook is quite negative, we’ll take new evidence as it comes.


    In any event, looking beyond the near-term horizon, I doubt that any shift in market action will meaningfully reduce the likelihood of a 40-55% loss in the S&P 500 over the completion of the current market cycle, nor the likelihood of 0-2% total returns for the S&P 500 on a 10-12 year horizon; both which imply that we fully expect the S&P 500 Index itself to be below present levels 10-12 years from today. Put simply, long-term investment outcomes are tightly linked to valuations, but near-term market outcomes are linked to investor attitudes toward risk-seeking and risk-aversion, which are best inferred from the uniformity of market internals across individual securities, industries, sectors, and security-types, including debt securities of varying creditworthiness.

      


  • Ruane Cunniff buysJD.Com, Yelp, Linkedin

    Ruane Cunniff (Trades, Portfolio) are value investors focused on the intrinsic value of business. They are long-term investors, and will buy a stock and hold it for a long time, even if sometimes the stocks seem to be overvalued. During the first quarter the investors bought shares in the following stocks.

    The guru acquired 4,843,324 shares in Dentsply Sirona Inc. (XRAY) with an impact of 2.32% on the portfolio.  


  • Wal-Mart Q1 2016 Results Lift Investors Mood

    Wal-Mart (NYSE:WMT) posted incredible first quarter sales numbers with shares surging more than 9% and numbers beating analysts’ expectations. Earnings per shares for the first quarter were $0.98 against analyst estimate of $0.88. This is higher than the discount retailer own EPS guidance of $0.80 to $0.95. Wal-Mart provided the customers with better shopping experience. Higher drug prices and strong demand for apparels bolstered the company’s sales. Same-store sales for the company surged 1% in the quarter, indicating 7 successive quarter of sales hike. Favourable pricing, selection and fully stocked shelves powered the Q1 sales of Wal-Mart in the grocery section.


    By the numbers

      


  • What Investors Need to Know About Target Corp. Q1 2016 Results

    Target Corp. (NYSE:TGT) posted its first quarter results recently and gave a cautious outlook on the back of increasing customer volatility. This impacted the company shares that fell as much as 11%, which is the retailer’s steepest intra-day decline in more than seven years. Target’s first quarter sales remained unimpressive, falling short of analyst expectations. Unseasonable weather and soft demand for electronics and groceries led to poor sales numbers.


    The company’s dismal numbers and weak outlook worried investors to the extent that they sold shares of other retailers including Wal-Mart Stores (NYSE:WMT), Macy's (NYSE:M), JC Penney (NYSE:JCP). Here’s a look at some key numbers and what to expect going forward.

      


  • Investors may Consider Adding Mondelez

    Company Overview


    Mondelēz International, Inc. (NASDAQ:MDLZ) is a global snacking powerhouse, with 2015 net revenues of approximately $30 billion. Creating delicious moments of joy in 165 countries, Mondelēz International is a world leader in biscuits, chocolate, gum, candy and powdered beverages, with billion-dollar brands such as Oreo, LU and Nabisco biscuits; Cadbury, Cadbury Dairy Milk and Milka chocolate; and Trident gum. Mondelēz International is a proud member of the Standard and Poor's 500, NASDAQ 100 and Dow Jones Sustainability Index. (Source: Company’s Website)

      


  • Outerwall is a Great Buy

    Company Overview


    Outerwall (NASDAQ:OUTR) has more than 20 years of experience creating some of the most profitable spaces for their retail partners. It delivers breakthrough kiosk experiences that delight consumers and generate revenue for retailers. As the company that brought consumers Redbox entertainment, Coinstar money services, and ecoATM electronics recycling kiosks, Outerwall is leading the next generation of automated retail and paving the way for inventive, scalable businesses. Outerwall kiosks are in neighbourhood grocery stores, drug stores, mass merchants, malls, and other retail locations in the U.S., Canada, Puerto Rico, the U.K., and Ireland. (Source: Company Website)

      


  • This Paper Giant Is Doing Well

    Company Overview


    International Paper (NYSE:IP) is a global leader in packaging and paper with manufacturing operations in North America, Europe, Latin America, Russia, Asia and North Africa. Its businesses include industrial and consumer packaging along with uncoated papers and pulp. Headquartered in Memphis, Tennessee, the Company employs approximately 55,000 people and is strategically located in more than 24 countries serving customers worldwide. (Source: Company Website)

      


  • Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Unilife Corporation


  • Suncor Energy announces restart of RMWB operations


  • Steven Cohen Invests in Netflix and ConocoPhillips

    Steven Cohen (Trades, Portfolio)’s top two transactions of the first quarter were acquisitions of stakes that are new to his portfolio – Netflix Inc. (NASDAQ:NFLX) and ConocoPhillips (NYSE:COP). The stakes aren’t entirely new, but Cohen hadn’t had shares in either one in his portfolio for more than a year.


    The numbers suggest the shares were overvalued.

      


  • Growing Generic Drug Market a Good Opportuity for 2 India Firms

    Given the growing market share for generic drugs, patient investors might want to consider two Indian pharmaceutical firms that are among the 10 largest generic drug companies in the U.S. -- Dr. Reddy’s Laboratories Ltd. (RDY) and Lupin Limited (NSE:LUPIN.NS).


    Although regulatory and currency issues have had a dramatic impact on the two Indian companies’ share prices, they are well positioned to capitalize on the burgeoning market for copies of brand-name drugs. In the U.S. alone, the generic drugs market was $66 billion in 2015, with several more familiar names among the leading providers, including Teva Pharmaceutical Industries (TEVA), Mylan N.V. (MYL) and the Sandoz unit of Novartis AG (NV).

      


  • When Opportunity Knocks, Answer the Door

    The upside of a canceled takeover offer



    Sharp sell-offs beckon brave, informed investors

      


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)